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Abstract
Background  and  objectives:  Postoperative  persistent  chronic  pain  (POCP)  is  a  serious  health
problem,  disabling,  undermining  the  quality  of  life  of  affected  patients.  Although  more  studies
and research  have  addressed  the  possible  mechanisms  of  the  evolution  from  acute  pain  to
chronic postoperatively,  there  are  still  no  consistent  data  about  the  risk  factors  and  prevention.
This article  aims  to  bring  what  is  in  the  panorama  of  the  current  literature  available.
Content:  This  review  describes  the  deﬁnition,  risk  factors,  and  mechanisms  of  POCD,  its  pre-
vention and  treatment.  The  main  drugs  and  techniques  are  exposed  comprehensively.
Conclusion:  Postoperative  persistent  chronic  pain  is  a  complex  and  still  unclear  etiology  entity,
which interferes  heavily  in  the  life  of  the  subject.  Neuropathic  pain  resulting  from  surgical
trauma is  still  the  most  common  expression  of  this  entity.  Techniques  to  prevent  nerve  injury
are recommended  and  should  be  used  whenever  possible.  Despite  efforts  to  understand  and
select risk  patients,  the  management  and  prevention  of  this  syndrome  remain  challenging  and
inappropriate.
© 2015  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/). Instituic¸ão: Universidade Federal da Bahia, Salvador, BA, Brasil; Universidade Federal de São Paulo, São Paulo, SP, Brasil.
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0104-0014/© 2015 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Dor  crônica  persistente  pós-operatória:  o  que  sabemos  sobre  prevenc¸ão,  fatores
de  risco  e  tratamento?
Resumo
Justiﬁcativa  e  objetivos:  A  dor  crônica  persistente  pós-operatória  (DCPO)  constitui  um  grave
problema de  saúde,  incapacitante,  mina  a  qualidade  de  vida  dos  pacientes  acometidos.  Apesar
de mais  estudos  e  pesquisas  terem  sido  desenvolvidos  a  respeito  dos  possíveis  mecanismos  da
evoluc¸ão da  dor  aguda  para  dor  crônica  pós-operatória,  ainda  não  existem  dados  consistentes
a respeito  de  seus  fatores  de  risco  e  prevenc¸ão.  Este  artigo  se  propõe  a  trazer  o  que  há  no
panorama  da  literatura  atual  disponível.
Conteúdo:  Esta  revisão  descreve  a  deﬁnic¸ão,  os  fatores  de  risco  e  os  mecanismos  da  DCPO,  sua
prevenc¸ão e  seus  tratamentos.  Os  principais  medicamentos  e  técnicas  são  expostos  de  forma
compreensiva.
Conclusão:  A  dor  crônica  persistente  pós-operatória  é  uma  entidade  complexa  e  de  etiolo-
gia ainda  não  esclarecida,  que  interfere  intensamente  na  vida  do  sujeito.  A  dor  neuropática
decorrente  do  trauma  cirúrgico  ainda  é  a  expressão  mais  comum  dessa  entidade.  Técnicas  que
evitem a  lesão  de  nervos  estão  recomendadas  e  devem  ser  usadas  sempre  que  possível.  Apesar
dos esforc¸os  para  entender  e  selecionar  os  pacientes  de  risco,  o  manuseio  e  a  prevenc¸ão  dessa
síndrome  continuam  desaﬁantes  e  inapropriados.
© 2015  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um
artigo Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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ostoperative  chronic  pain  (POCP)  has  been  the  focus  of
everal  investigations  in  recent  years,  contributing  to  solve
ncertain  questions  on  the  subject,  such  as  the  possible  evo-
utionary  mechanisms  of  acute  pain  to  POCP.  However,  there
re  few  consistent  data  in  the  literature,  so  this  article  aims
o  draw  a  picture  of  the  current  literature  available.  Usu-
lly,  the  therapeutic  options  for  the  overall  improvement  of
OCP  are  not  yet  deﬁned,  which  facilitates  the  occurrence
f  disability  and  direct  interference  in  the  quality  of  life  of
ffected  patients.  POCP  has  been  described  for  a  number  of
iseases  of  varied  duration,  mainly  characterized  by  a  lack
f  understanding  of  the  factors  that  initiated  or  maintained
ts  development.  It  is  known  that  such  factors  involved  in
his  process  of  chronicity  may  be  biological,  psychological,
nd  social.1
eﬁnition
ersistent  postoperative  chronic  pain  (POCP)  is  deﬁned  as
ain  lasting  for  two  or  more  months  after  surgery,  when
ther  causes  of  pain  are  excluded,  such  as  cancer  or  chronic
nfection.2
In  the  immediate  postoperative  period,  direct  activa-
ion  of  nociceptors,  inﬂammation,  and  possible  damage  to
erve  structures  cause  pain  at  rest  or  incident  pain  at  the
urgical  site  and  nearby  region.  There  is  pain  evoked  by
ouching  the  wound,  motion,  breathing,  coughing,  or  gas-
rointestinal  activity.  There  may  also  be  effective  nerve
amage,  a  neuropathic  component  may  develop  immedi-
tely  after  surgery  and  persist  in  the  absence  of  peripheral
m
h
v
dociceptive  or  inﬂammatory  stimulus.  Thereby  deﬁning
europathic  pain  is  essential  to  develop  strategies  for
ersistent  chronic  pain  prevention  and  treatment.  Gen-
rally,  there  are  signs  of  nerve  injury,  especially  after
erniorrhaphy,  mastectomy,  thoracotomy,  and  mandibular
steotomies.3 It  is  important  to  understand  that  POCP  is
nitiated  by  an  event  and  maintained  regardless  of  what
aused  it.  Persistent  chronic  pain  after  surgery  has  been
he  main  factor  interfering  with  the  individual’s  return
o  daily  life  activities,  which  affects  his/her  capacity  and
roductivity.1
ncidence
lthough  poorly  documented  in  the  literature,  the  inci-
ence  of  POCP  is  very  variable  and  occurs  after  both  highly
omplex  operations  and  minor  surgeries.  Between  5%  and
0%  of  patients  develop  chronic  pain  after  surgical  pro-
edures,  particularly  those  that  cause  nerve  damage.4--6
he  incidence  of  POCP  is  30--81%  after  limb  amputation,
1.5--47%  after  thoracotomy  and  inguinal  hernia,  3--56%
fter  cholecystectomy,4 10--50%  after  breast  surgery,7 15%
fter  vasectomy,8 6--18%  after  cesarean,  and  4--10%  after
ormal  delivery.9
This  wide  variation  in  incidence  may  be  associated  with
ifferent  deﬁnitions  used  for  POCP  in  several  studies.10,11 In
his  study,  we  consider  the  deﬁnition  by  Macrae:  the  pain
ust  develop  after  surgical  procedure,  with  at  least  two
onths  duration,  and  is  not  related  to  pre-existing  pain  and
ave  no  other  deﬁned  etiologies.12 Other  causes  for  such
ariability  are  the  evaluation  and  interpretation  of  pain  syn-
rome  types  and  the  various  study  designs.11
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Risk factors
Among  the  factors  that  may  be  linked  to  postopera-
tive  chronic  persistent  pain  are  age,  sociocultural  factors,
obesity,  genetic  load,  history  of  previous  surgery,  sur-
gical  technique  used,  muscle  ischemia,  nerve  damage,
type  of  analgesia,  and  presence  of  preoperative  pain.13--15
Preexisting  painful  conditions  (irritable  bowel  syndrome,
migraine,  ﬁbromyalgia,  Raynaud’s  disease,  among  others)
and  psychological  aspects,  such  as  fear  of  the  proce-
dure,  pain  expectation,  and  pain  catastrophizing  are  also
associated.12
Younger  patients  undergoing  thoracotomy  had  a  higher
incidence  and  severity  of  pain  than  older  patients,  but
the  pain  was  more  easily  controlled.10 Contrary  to  what
was  believed,  sex  may  not  have  much  inﬂuence  on  the
development  of  POCD,  with  conﬂicting  ﬁndings  in  the
literature.15 By  genetic  character,  the  functional  poly-
morphism  of  catecholamine-O-methyltransferase  (COMT)
is  related  to  the  change  and  exacerbation  of  pain
sensitivity.3
In  thoracotomy,  posterolateral  and  subcostal  incisions
contribute  to  the  occurrence  of  POCP,1,16 are  more  painful
than  medians,  and  the  use  of  rib  retractors  further
increase  this  differentiation  due  to  reduced  electrical
conduction  of  adjacent  intercostal  nerves.3 In  abdom-
inal  surgery,  transverse  and  oblique  access  techniques
cause  less  pain  and  impaired  lung  function  than  the  mid-
line  approaches,  particularly  in  the  ﬁrst  24  h,  although
there  are  no  differences  in  perioperative  and  postopera-
tive  complications  and  recovery  time.17 The  severity  of
immediate  postoperative  pain  can  also  increase  the  occur-
rence  of  pain  after  cholecystectomy  or  limb/breast  phantom
pain.3
A  study  evaluating  factors  associated  with  postoperative
pain  in  liver  donor  patients  showed  that  anxiety  and  num-
ber  of  given  analgesics  were  related  to  the  chronicity  of
the  painful  process.18 Psychosocial  vulnerability,  depression,
stress,  hospital  stay,  and  delay  to  return  to  daily  activities
are  important  risks  of  psychic  origin  for  persistent  postop-
erative  chronic  pain.19
Mechanisms of persistent postoperative
chronic  pain
The  mechanisms  of  postoperative  chronic  pain  are  com-
plex  and  not  fully  understood.  Different  mechanisms  are
responsible  for  different  pain  syndromes,  even  in  one  type
of  surgery.11
The  surgical  stimulus  and  tissue  trauma  that  results
from  incision  cause  postoperative  inﬂammatory  reaction
which  only  terminates  with  the  ﬁnal  healing  process;
thus,  facilitating  the  process  of  neuroplasticity  and
consequent  changes  in  neuronal  membrane  excitability.  Fur-
thermore,  there  is  a  possible  reduction  of  the  central
inhibitory  mechanisms  and  increased  excitatory  synaptic
efﬁcacy.20,21Neuroplasticity  can  be  divided  into  two  interconnected
types:  peripheral  and  central.  Peripheral  neuroplastic-
ity  occurs  from  the  release  of  inﬂammatory  media-
tors  (cytokines,  prostaglandins,  bradykinin,  histamine,
s
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erotonin,  H+  ions)  by  damaged  tissues  or  inﬂammatory
ells,  with  activation  of  intracellular  cascades  that  cul-
inate  in  reducing  the  excitatory  threshold  and  may
ause  pain  perception  with  a  reduced  stimulus  (allo-
ynia)  or  increased  response  to  aggressive  stimulus
hyperalgesia).3
Similarly,  in  central  neuroplasticity  there  is  also
ncreased  synaptic  efﬁcacy  for  pain  transmission.3 A  periph-
ral  nociceptive  stimuli  may  cause  the  activation  of
ntracellular  pathway  of  protein  kinases  in  the  spinal  cord
orsal  horn  and  modify  the  expression  of  ion  channels
nd  receptor  and  neurotransmitter  density  which  facili-
ate  nerve  hyperexcitability.  There  is  increased  activity
nd  density  of  aminopropanoic  acid  (AMPA)  and  N-methyl-d-
spartate  (NMDA)  receptors,  subsequent  production  of  nitric
xide  (NO),  activation  of  protein  kinases  (PKA  and  PKC)
nd  other  second  messengers.20,22 The  NO  stimulates  the
elease  of  prostaglandin  E2  and,  as  transcellular  neuromedi-
tor,  leaves  the  cell  and  ampliﬁes  the  postsynaptic  release
f  aspartate,  glutamate,  and  substance  P  (SP),  and  acti-
ates  even  more  speciﬁc  receptors.  Thus,  the  increase  of
lutamatergic  synapses  in  the  dorsal  horn  of  the  spinal  cord,
aused  by  the  initial  pain  stimulus,  reinforces  the  transmis-
ion  of  new  nociceptive  stimuli  and  recruits  non-nociceptive
timuli  to  the  pain  pathway.22 At  the  end  of  the  central
ensitization  induction  chain,  the  responsiveness  of  neurons
ncreases  and,  even  those  that  usually  have  an  ineffective
ynapse  to  innocuous  stimuli,  start  to  activate  the  neuronal
ransmission  of  pain.3
The  propagation  mechanism  of  postoperative  pain  fol-
owing  direct  peripheral  nerve  injury  varies  widely.  The
ajor  injury  of  nerves  that  are  located  in  the  surgical  ﬁeld  of
ost  procedures  is  probably  a  prerequisite  for  the  develop-
ent  of  POCP.3 In  a  study  of  thoracotomy  with  and  without
ntercostal  nerve  protection,  lower  pain  score  was  found  in
atients  who  had  their  intercostal  nerve  protected  after
--7  days  postoperatively.  However,  this  ﬁnding  was  not
aintained  in  the  evaluation  one  month  after  surgery.23 In
nother  article,  the  authors  performed  an  electrophysiolog-
cal  study  of  patients  undergoing  thoracotomy  and  assessed
ntercostal  nerve  damage  before  and  three  months  after  the
rocedure;  there  was  no  association  between  intercostal
erve  damage  and  pain  or  sensitivity  change  at  the  end  of
ollow-up.2
revention
arly  and  late  post-surgical  pain  prevention  is  a  major
hallenge  for  anesthesiologists  and  surgeons  because  POCP
reatment  is  difﬁcult.  In  an  attempt  to  improve  patient
anagement  in  the  perioperative  period  and  predict  possi-
le  postoperative  pain,  more  studies  addressing  this  issue
re  being  developed  every  day.  It  is  necessary  to  edu-
ate  the  medical  staff  so  that  effective  measures  are
aken  and  unnecessary  and  inappropriate  operations  are
inimized.13
Human  and  experimental  animal  studies  indicate  that
ome  of  neuroplastic  changes  (spinal  sensitization)  after
rauma  can  be  prevented  through  aggressive  treatment
f  acute  pain.  However,  the  hypothesis  that  preventive
nalgesia  can  promote  clinically  signiﬁcant  reduction  of
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ost-operative  pain  severity  or  duration  remains  unan-
wered.  Controlled  clinical  trial  data  were  not  favorable,
lthough  there  are  studies  with  positive  results.
Multimodal  analgesia  with  combined  drugs  having  differ-
nt  mechanisms  of  action  and  additive  or  synergistic  effects
eems  to  interfere  appropriately  with  the  pain  complexity
ransmission.1 Drug  combination,  in  addition  to  contem-
late  the  various  inhibitory  targets  of  pain  pathophysiology,
lso  promotes  signiﬁcant  reductions  in  adverse  effects  by
ecreasing  the  dosage  required.  In  the  case  of  opioids,  there
s  a  20--40%  decrease  of  unwanted  effects,  particularly  nau-
ea,  vomiting,  and  sedation.24 Multimodal  regimens  have
ocused  on  the  use  of  opioids,  2-adrenergic  agonists,  COX
ntagonists,  gabapentin,  pregabalin,  steroids,  NMDA  antag-
nists,  and  local  anesthetics.25
POCP  prevention  must  be  done  not  only  by  the  anesthe-
iologist,  but  also  by  the  surgical  team.  Patients  undergoing
urgical  procedures  should  be  aware  of  the  risk  of  POCP,
iven  its  high  incidence.  Each  elective  surgery  should  be
valuated  carefully,  with  assessment  of  risks  and  beneﬁts.
he  staff  should  know  the  different  surgical  techniques  to
hich  the  patient  can  be  subjected,  choosing,  when  pos-
ible,  the  technique  with  the  lowest  risk  of  developing
OPD.
Careful  dissection  of  the  surgical  ﬁeld  and  less  inva-
ive  techniques  can  be  strategies  to  prevent  pain  while
voiding  nerve  damage  and  minimizing  local  inﬂammatory
rocess.26 For  thoracotomy,  preference  should  be  given  to
he  anterolateral  approach  and  less  invasive  techniques.3
n  abdominal  surgery,  studies  have  found  that  the  use  of
lectrocautery  may  require  less  use  of  analgesics  in  the  post-
perative  period,  and  that  the  use  of  diathermy  initiated
n  periods  shorter  than  the  ﬁrst  24  h  after  surgery  signiﬁ-
antly  reduced  pain.16 In  the  speciﬁc  example  of  inguinal
ernia  correction,  procedure  with  a  high  rate  of  POCD,
urgeons  should  avoid:  (1)  indiscriminate  division  of  the
ubcutaneous  tissue;  (2)  removal  of  the  cremaster  muscle
bers;  (3)  excessive  dissection  of  the  ilioinguinal  nerve;  (4)
amaging  the  neural  structures  (stretching,  bruising,  cut-
ing,  grinding,  cauterization,  suturing);  (5)  overtighten  the
nguinal  ring;  (6)  suturing  the  edge  of  the  internal  oblique
uscle.15
A  scale  to  assess  the  risk  probability  of  developing
OCP,  including  some  predictors  such  as  age,  sex,  preop-
rative  pain,  type  of  surgery,  incision  size,  level  of  anxiety,
mong  others,  was  developed  and  validated  in  outpatient
nd  hospital  patients,  showed  a  good  correlation  with  the
evelopment  of  postoperative  acute  pain.27 Because  acute
ostoperative  pain  is  associated  with  the  risk  of  developing
hronic  pain,  identifying  possible  risk  patients  allow  more
nd  more  preventive  measures  to  be  taken  throughout  the
erioperative  period  in  an  attempt  to  block  the  development
f  POCP.
Effective  prevention  of  POCP  must  follow  a  list  of
oals:
 Perioperative  analgesia
 Surgery  with  less  trauma
 Avoid  nerve  damage
 Avoid  compression  of  structures
 Improve  venous  return
g
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 Control  diabetes  mellitus
 Early  mobilization
nesthetic approaches for  persistent
ostoperative chronic pain prevention
harmacological
ntidepressants
he  use  of  antidepressants  for  treating  postoperative
hronic  pain,  particularly  in  cases  of  neuropathic  pain,
s  well  established  in  the  literature.28 However,  the  het-
rogeneity  of  this  group  of  drugs  and  studies  performed
o  not  allow  conclusions  about  its  role  in  POCD  pre-
ention,  although  positive  results  have  being  reported
rom  its  perioperative  use.29 The  main  argument  for  its
se  is  to  reduce  the  central  sensitization  provided  by
hese  drugs  mechanism  of  action.  Its  routine  use  is  not
ndicated  because  there  is  no  evidence  of  beneﬁts  that
utweigh  the  possible  adverse  effects,  such  as  increased
erioperative  bleeding  and  serotonin  syndrome,  among
thers.30--32
abapentin
abapentin  mechanism  of  action  is  by  reducing  the  hyper-
xcitability  of  spinal  dorsal  horn  neurons  induced  by  acute
njury,  responsible  for  central  sensitization.  This  occurs  via
ostsynaptic  binding  of  gabapentin  to  voltage-gated  cal-
ium  channel  2-  subunits  in  spinal  dorsal  horn  neurons,
hich  reduces  the  entry  of  calcium  into  nerve  endings
nd  reduces  the  release  of  excitatory  neurotransmitters.33
urthermore,  gabapentin  can  act  on  NMDA  receptors,
odium  channels,  monoaminergic  pathways,  and  opioid
ystem.34--37
In  a  multimodal  analgesia  study,  which  includes
abapentin  and  local  anesthetic  given  by  various  routes
o  patients  undergoing  mastectomy,  there  was  less  con-
umption  of  analgesics,  better  control  of  acute  pain,  and
ersistent  reduction  of  about  30%  in  this  group,  com-
ared  to  control  group.  In  a  second  randomized  study38
f  patients  undergoing  thyroidectomy,  previous  use  of
abapentin  reduced  the  incidence  of  neuropathic  pain  up
o  6  months  postoperatively.39
In  a  review,  the  authors  concluded  that  patients  who
eceived  gabapentin  (300--1800  mg  day−1) as  a  single  dose
4  h  before  surgery,  or  those  receiving  it  up  to  10  days
fter  surgery,  required  a lower  dose  of  opioid  and  had  lower
ain  scores  postoperatively.  Postoperative  opioid  consump-
ion  was  lower  in  the  single-dose  gabapentin  group  in  14  of
he  17  studies  assessed.  In  the  pre-  and  postoperative  treat-
ent  group,  opioid  consumption  was  lower  in  seven  studies.
ate  pain  assessments  were  performed  in  four  studies  (after
0  days  in  two  and  after  three  months  in  two)  and  there
as  difference  only  in  one  of  them.  The  authors  concluded
hat  to  achieve  improved  pain  symptoms,  a  single  dose  of
abapentin  1200  mg  preoperatively  seems  to  be  sufﬁcient.
he  use  of  higher  doses  and  for  longer  periods  increased  the
ncidence  of  related  side  effects,  such  as  sedation,  dizzi-
ess,  nausea  and  vomiting.40
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Pregabalin
With  a  mechanism  of  action  similar  to  gabapentin,  but  with
superior  pharmacokinetic  effect,41 pregabalin  is  an  effec-
tive  drug  known  for  treating  various  pain  syndromes.  It
has  remarkable  ability  to  enhance  the  analgesic  potency
of  opioids  and  reduce  respiratory  depression,  in  addi-
tion  to  having  no  deleterious  effects  on  gastrointestinal
mucosa  and  kidney  function,  as  well  as  being  easier  to
dose.42
Ketamine
Ketamine  action  is  quite  complex,  as  its  molecule  interacts
with  various  types  of  receptors  present  in  several  binding
sites----such  as  GABAergic  receptors;  opioids;  monoaminer-
gics;  cholinergics;  glutamatergics;  and  ion,  calcium,  sodium,
and  potassium  channels.43 Its  main  analgesic  activity  occurs
through  antagonism  in  N-methyl-d-aspartate  (NMDA)  recep-
tor,  as  it  plays  an  important  role  in  the  processing  of
pain  stimuli  by  prolonging  and  amplifying  the  nociceptive
responses.44
NMDA  receptors  are  inactivated  by  ketamine  through  a
non-competitive  blockade  by  binding  to  the  phencyclidinic
site  within  the  receiver  channel,  partially  coating  the  mag-
nesium  binding  site,  and  changing  the  channel  open  time.
Ketamine  afﬁnity  S(+)  for  this  binding  site  is  three  to  four
times  higher  than  that  of  its  R(-)  isomer  and,  hence,  its  anal-
gesic  and  anesthetic  strength  when  isolated  is  twice  that
of  the  racemic  mixture,  explained  by  the  hypothesis  that
NMDA  receptor  blockade  is  this  drug’s  main  mechanism  of
action.44
The  analgesic  properties  of  ketamine  are  also  expressed
by  other  secondary  mechanisms:  activation  of  the  descen-
ding  inhibitory  monoaminergic  system,  which  is  involved
in  the  modulation  of  nociceptive  processes  and  is  gen-
erally  activated  by  systemic  opioids;  activation  of  other
receptor  systems,  such  as  opioid  and  cholinergic;  blockade
of  sodium  channels,  in  an  action  similar  to  that  of  local
anesthetics.45
Ketamine  can  be  used  to  prevent  chronic  persistent
pain  with  good  results  by  multimodal  and  balanced  anal-
gesic  regimens.  In  a  study  of  patients  who  underwent
colon  resection,  the  use  of  intravenous  ketamine  during
surgery  associated  with  epidural  anesthesia  signiﬁcantly
reduced  pain  levels  by  up  to  six  months  after  the
procedure.45
Clonidine
Clonidine  provides  analgesia  by  selective  postsynaptic
action  in  2-agonist  receptors  of  spinal  dorsal  horn,  mimick-
ing  the  action  of  norepinephrine.  It  also  interacts  with  the
cholinergic  pathways,  as  intrathecal  clonidine  increases  the
concentration  of  acetylcholine  in  sheep  and  humans.  There
is  inhibition  of  adenylate  cyclase  and  voltage-dependent
calcium  channels  and  increased  potassium  channel  open-
ing  time.  This  leads  to  the  release  suppression  of  excitatory
neurotransmitters  and,  consequently,  of  neuronal  excitation
in  the  central  nervous  system  areas  associated  with  pain
perception.46
An  experiment  with  patients  undergoing  colon  surgery
demonstrated  that  the  use  of  subarachnoid  clonidine  at
a  dose  of  300  g  reduced  the  postoperative  incidence  of
t
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hronic  pain  after  six  and  12  months  of  surgery,  compared
ith  the  use  of  bupivacaine  alone  by  the  same  route.47 One
hould  bear  in  mind  the  effects  of  sedation,  hypotension,
radycardia,  and  prolonged  nerve  block  that  can  accompany
he  use  of  this  drug.48
ther  drugs
urther  studies  are  necessary  for  the  emergence  of  new
rugs  with  preventive  analgesic  effects  and  determination
f  doses  and  appropriate  duration  of  treatment  required
o  reduce  the  central  and  peripheral  sensitization.  Several
rugs  have  been  studied,  such  as  minocycline  that  mod-
lates  glia  and  inhibits  apoptosis  of  dorsal  root  ganglion
ells;49 antagonists  of  excitatory  receptors  in  glial  cells;
odium  channel  blockers  (Nav1.7,  Nav1.8,  Nav1.3);  agents
hat  facilitate  potassium  channel  opening,  hyperpolarize
he  membrane;  calcium  channel  inhibitors;  high  concentra-
ion  capsaicin;  cannabinoid  receptor  agonists;  among  other
ossibilities.50
Another  area  for  clinical  research  focuses  on  the  devel-
pment  of  protocols  to  identify  the  variation  between
ndividuals  in  the  response  to  pain  to  the  same  surgical  stim-
lus.  Genetic  testing  should  enhance  the  ability  of  clinicians
o  differentiate  patients  who  respond  with  mild  or  severe
ain  to  the  same  nociceptive  stimuli.  Pharmacogenetics  can
lso  help  identify  the  genetic  polymorphism  of  receptors  for
rugs  that  may  inﬂuence  the  need  or  response  to  certain
nalgesics.51
egional  anesthesia
ocal  anesthetics  have  always  been  used  in  regional  anes-
hesia  and  analgesia.  By  blocking  sodium  channels  in
erve  membranes,  these  agents  interrupt  the  conduction
f  nociceptive  stimulus  from  injury  site  to  central  ner-
ous  system  and  prevent  the  onset  of  its  sensitization
ascade.52
ocal  inﬁltration
ocal  inﬁltration  of  skin  and  subcutaneous  tissue  before
he  incision  is  a  simple,  safe,  and  easy  to  use  method,
ith  few  adverse  events  and  low  risk  of  toxicity.  Its
nhibitory  effects  on  local  inﬂammation,  together  with
he  blockade  of  nociceptive  ﬁbers,  contribute  to  reduce
he  neuronal  sensitization.53,54 Although  some  authors
ave  shown  that  the  administration  of  local  anesthetic
efore  incision  reduces  consumption  and  increases  the
ime  to  request  analgesics,  others  found  no  differences
etween  those  who  underwent  inﬁltration  at  the  end  of
urgery.55
A  review  of  inguinal  hernia  repair  showed  signiﬁcant
eductions  in  the  scale  of  the  immediate  post-operative  pain
nd  additional  analgesia  consumption  up  to  50%  lower  in
atients  undergoing  local  anesthetic  inﬁltration.56 In  hys-
erectomy,  the  use  of  bupivacaine  in  the  wound  allowed
ower  consumption  of  analgesics  for  up  to  three  days  after
he  procedure,  although  there  were  no  differences  between
ain  measurements  in  the  visual  scale.57 It  is  also  unclear
hether  this  method  prevents  chronic  pain,  as  most  studies
ssess  pain  within  24--48  h.
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Intra-articular  infusion  of  local  anesthetic  (arthroplasty
nd  other  knee  surgeries)  can  reduce  pain,  postoperative
leeding,  opioid  consumption,  and  allow  a  more  com-
ortable  rehabilitation.58 Furthermore,  in  removal  of  iliac
rest  bone  graft,  this  technique  can  avoid  the  incidence
f  iliac  bone  chronic  pain  in  4-year  follow  up.59 It  is
mportant  to  remember  that  local  anesthetic  infusion  in
mall  joints,  such  as  hands,  can  cause  chondrotoxicity  and
nfection.60
eripheral  nerve  block
he  use  of  nerve  block  is  associated  with  improved  recov-
ry  and  reduced  rate  of  hospital  readmission  of  the  patient
hen  compared  to  general  anesthesia.61 A  continuous  infu-
ion  of  local  anesthetic  causes  better  analgesia  reduces  the
onsumption  of  opioids  and  adverse  effects  (nausea,  vomi-
ing,  sedation,  and  pruritus).  The  technical  skill  and  the
ecessary  infrastructure  for  managing  catheters,  however,
re  factors  that  still  hinder  the  applicability  of  this  method.
lthough  there  is  no  evidence  for  prevention  of  chronic
ain,  continuous  peripheral  nerve  block  provides  better
ontrol  of  postoperative  pain  than  systemic  analgesia,61
educes  hospital  stay  with  improved  recovery  and  sleep
uality.62--64
euraxial  block
euraxial  blocks  can  inhibit  the  response  to  trauma,  prevent
eripheral  transmission  of  nociceptive  stimuli  to  central  ner-
ous  system  and,  thus,  reduce  neuronal  remodeling  and  the
ossibility  of  developing  POCD.  There  are  also  other  ben-
ﬁts,  such  as  reduced  mortality,  deep  venous  thrombosis,
ulmonary  embolism,  respiratory  complications,  and  other
orbidities.65
The  incidence  of  persistent  chronic  pain  six  months
fter  thoracotomy  can  be  reduced  about  34%  using  thoracic
pidural  analgesia  with  local  anesthetic  at  the  beginning
f  surgery  and  postoperative  maintenance.66 In  orthopedic
urgery,  epidural  block  can  minimize  the  risk  of  devel-
ping  regional  complex  syndrome  postoperatively,  while
ome  authors  suggest  that  it  may  also  reduce  the  inci-
ence  of  phantom  pain  in  amputees.4 Although  theoretically
avorable,  the  ﬁndings  of  current  literature  on  the  use
f  intrathecal  and  caudal  blockades  to  prevent  POCD  are
nconsistent.55
onclusion
ersistent  postoperative  chronic  pain  is  a  complex  entity
hose  etiology  is  not  fully  elucidated,  which  affects  the
uality  of  life  of  individuals.  Neuropathic  pain  result-
ng  from  surgical  trauma  is  still  the  most  common
xpression  of  this  entity.  For  its  prevention,  appropri-
te  perioperative  analgesia  is  essential  and  techniques
hat  avoid  nerve  damage  are  recommended  and  should
e  used  whenever  possible.  Despite  the  efforts  of  inves-
igators  to  understand  and  select  patients  at  risk,  the
anagement  and  prevention  of  this  syndrome  are  still
nappropriate.
2D.C.  Kraychete  et  al.
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